A pharmacy used to feel like one of the more ordinary places of healthcare. A prescription was sent in, a patient stopped by after work, and someone behind the counter helped make sure the medication made sense.
Over time, that familiar errand became part of a much bigger business, as CVS and Walgreens expanded across the country and used thousands of locations to negotiate drug costs that smaller pharmacies rarely qualify for.
By 2025, the four largest pharmacy operators, CVS Health, Walgreens, Cigna, and UnitedHealth Group, controlled more than half of U.S. prescription dispensing revenue. Scale like that has made the business harder for roughly 19,000 independent community pharmacies to manage.
And much of the strain comes from Pharmacy Benefit Managers, or PBMs, which are hired by insurers and employers to manage prescription drug benefits and help decide how much pharmacies are paid.
As those payments come under pressure, local pharmacies are trying to protect already narrow margins while keeping up with online refills and faster pickup that patients have come to expect. That leaves independent pharmacies trying to hold their place in a market that keeps rewarding scale, even as many communities still depend on what local pharmacies do differently.
American patients visit their community pharmacy one and a half to two times more often than they see a doctor, and for many of them, the pharmacist is the healthcare professional they know best.
A Consumer Reports study cited by Pharmacy Times found that more than half of independent pharmacy patients said their pharmacist knew them by name, compared with just 14% at chain pharmacies. And knowing a patient by name often means knowing their medications, their history, and the questions they haven’t thought to ask yet.
Rural communities depend on this even more, since many have an independent pharmacy as their only nearby healthcare option, and when one closes, the surrounding pharmacies have to absorb all those displaced patients at once with the same staff and daily pressures.
Ky Davis, who owns Harris Pharmacy in Rocky Ford, Colorado, has seen what that looks like up close, and his reason for continuing to fill prescriptions, even when some lose money, comes back to a responsibility that is bigger than the transaction.
“It’s an obligation to our community to take care of them,” Davis said. “Even if we continue to lose money, doing those prescriptions is really a public service.”
And that same responsibility shows up in the services many independents now provide alongside prescriptions. The 2024 NCPA Digest found that 91% of independent pharmacies offered flu vaccines, making them one of the most dependable options for preventive care in places where getting to a doctor’s office isn’t always easy.
Running a pharmacy that a community depends on and keeping it financially healthy are two very different problems, and for most independent pharmacies, the second has gotten much harder.
The three largest PBMs, OptumRx, Express Scripts, and CVS Caremark, manage roughly 79% of all U.S. prescription claims, and the rates they set often fall below what independent pharmacies paid for those same drugs.
The 2024 NCPA Digest also found that 67% of independent owners were struggling to find pharmacy technicians, adding another strain on stores whose gross profit margins had already fallen to 19.7% in 2023, their lowest point in a decade.
Patients have come to expect the digital tools and fast service that national chains have spent years building, and matching that on an independent budget is its own challenge. The pressure these pharmacies face is difficult because it shows up in every part of the business, from the reimbursement on a single prescription to the staff hours needed to keep the counter moving.
Many, however, are responding by rethinking how they operate from the inside out, and the tools now available to them are making that more practical than it used to be.
Small pharmacies have always been able to move faster than a national chain, and the management tools available to them today have made that speed much more useful.
A pharmacy management system is essentially the operating software a pharmacy runs on, handling everything from prescription processing and inventory tracking to refill reminders and delivery coordination, all within a single platform.
Research published in the National Library of Medicine found that independent pharmacies actually adopt digital health tools more easily than large retail chains. This is because smaller operations can test and implement changes without waiting for corporate approval, and that speed is what makes access to better technology more important for a single-location owner.
Platforms built specifically for independent pharmacies, like PrimeRx, have been building this kind of software for more than 30 years, giving independent operators the same day-to-day capabilities that national chains have spent enormous resources building internally.
Technology alone does not erase the financial pressures these pharmacies face, but it does give owners more control over how they manage them, and for a small pharmacy trying to hold its own against companies with far deeper pockets, that kind of control makes a big difference.
Better systems give independent pharmacies more visibility, but visibility only helps if owners use it to protect cash.
Pharmacy owners are looking more closely at inventory turns, payroll ratios, and gross margins because even small leaks make an already difficult business harder to run. However, group purchasing organizations help smaller pharmacies address the buying side of that problem.
Instead of negotiating alone, independents pool their orders with other pharmacies to improve purchasing terms, then use their own store data to decide which medications and products are actually worth keeping on the shelf.
Some pharmacies have taken that financial discipline further by building around services their communities need most, from compounding and specialty medications to long-term care support. And those services tend to carry better margins than standard dispensing.
More importantly, they give independent pharmacies a role in their communities that cannot be reduced to price or convenience.
Pharmacists are often among the easiest healthcare providers to reach, and experts say a provider’s recommendation is one of the strongest reasons patients accept a vaccine. That makes the pharmacy counter a practical place for preventive care, from routine immunizations to point-of-care testing for flu, strep, or COVID-19.
Clinical pharmacists are also playing a larger role in medication management, helping people understand what they take, why it matters, and how to stay on track.
Research presented at the NAACOS Spring 2026 Conference found that when pharmacists actively help patients manage their medications, those patients take them more consistently and are readmitted to the hospital less often. When a patient comes back regularly and trusts their pharmacist, health problems are more likely to be caught before they become harder to fix.
Retail pharmacy is still consolidating. From 2010 to 2025, CVS and Walgreens acquired more than 6,000 locations from smaller competitors, adding more pressure to a market already shaped by size.
Policy may change some of that pressure, especially as PBM practices draw more scrutiny from lawmakers, regulators, and employers. But independent pharmacies cannot build their future around reform alone. The stronger path is building an operation that is too specific and too trusted to be easily replaced.
Independent pharmacies compete with national chains every day, and the strongest operators are doing it on terms large retailers have found difficult to match. Their strength comes from relationships and local knowledge that take years to earn and cannot be copied by opening another location.
Big retail will continue to have size on its side, but independent pharmacies do not have to win by becoming smaller versions of national chains. Their future depends on using technology and smarter operations to protect what made them valuable in the first place.